Donia Skanji
Gif-sur-yvette, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Integrating Preclinical Insights for Adaptive Dose Escalation in Phase I Oncology Trials.
Journal: Pharmaceutical statistics
Published: June 02, 2025
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial design.
Journal: Future oncology (London, England)
Published: February 23, 2025
Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials.
Journal: Statistics in medicine
Published: February 22, 2025
Dual-Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time-to-Event Group Sequential Trials.
Journal: Statistics in medicine
Published: November 25, 2024
A comparison of model-free phase I dose escalation designs for dual-agent combination therapies.
Journal: Statistical methods in medical research
Published: January 24, 2024
Futility Interim Analysis Based on Probability of Success Using a Surrogate Endpoint.
Journal: Pharmaceutical statistics
Published: January 09, 2024
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: October 26, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026